NCT04798495

Brief Summary

Non-myeloablative allogeneic haematopoietic stem cell transplantation (NMA-HSCT) is associated with innumerable complications and side-effects and a high treatment-related mortality. Maintaining quality of life, physical and psychosocial functioning and participation in society is therefore challenging for patients undergoing treatment with NMA-HSCT. This situation creates an urgent need for rehabilitation for patients to return to a meaningful everyday life, and for knowledge about how to best help this group of patients return to everyday life. The project aims to develop and examine the feasibility and safety of a multimodal interdisciplinary rehabilitation programme targeted patients undergoing treatment with NMA-HSCT. Three studies are planned. Study I is a qualitative interview study to get a profound insight into patients' experiences and challenges after NMA-HSCT. Study II has a single arm longitudinal design with both a feasibility and an outcome component. Patients (N=30) are consecutively recruited at the Department of Haematology, Aarhus University Hospital, Denmark and enrolled in the 6-month HAPPY programme as soon as the decision about NMA-HSCT is final. Data is collected pre-NMA-HSCT, at 3-month, 6-month and 12-month after NMA-HSCT. Study III is a qualitative interview study, where patients who participated in the rehabilitation programme evaluate the programme's influence on their return to everyday life. The project contributes with knowledge about the feasibility of a rehabilitation programme targeted at a vulnerable group of chronic cancer patients with rare diseases. We will document the impact of an interdisciplinary intervention anchored in the hospital setting but aimed at reaching patients at home. If the intervention enhances quality of life, patient activation and functioning, it may not only reduce the number of hospitalizations and use of healthcare services, but may also allow more patients to maintain contact with the labour market and resume participation in society.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2018

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 23, 2021

Completed
20 days until next milestone

First Posted

Study publicly available on registry

March 15, 2021

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2021

Completed
Last Updated

November 10, 2021

Status Verified

December 1, 2020

Enrollment Period

2.4 years

First QC Date

February 23, 2021

Last Update Submit

November 2, 2021

Conditions

Outcome Measures

Primary Outcomes (10)

  • Recruitment rate

    Number of patients who accepted to participate in the study out of patients treated with non-myeloablative allogeneic haematopoietic stem cell transplantation

    Baseline - 6-month follow-up

  • Attrition and reasons for drop out

    Number of drop-outs of patients participating in the study

    Baseline - 6-month follow-up

  • Exposure to physical exercise training per patient

    The percentage of physical exercise training used by the patients when he/she was at the hospital and reason(s) for non-participation

    Baseline - 6-month follow-up

  • Exposure to motivating interviewing per patient

    The percentage of motivating interviewing used by the patients out all planned, and reason(s) for non-participation

    Baseline - 6-month follow-up

  • Exposure to group sessions topics together with fellow patients and relatives per patient

    The percentage of group sessions with different topics used by the patients out all planned, and reason(s) for non-participation

    Baseline - 6-month follow-up

  • Exposure to nutritional counselling per patient

    The percentage of nutritional counselling used by the patients out of planned, and reason(s) for non-participation

    Baseline - 6-month follow-up

  • Exposure to digital physical exercise programme per patient

    The percentage usage of the digital exercise programme out of possible/planned digital exercise trainings, and reason(s) for non-participation

    Baseline - 6-month follow-up

  • Exposure to phone calls to patients staying at home

    The percentage use of phone calls by patients while they stay at home, and reason(s) for unused

    Baseline - 6-month follow-up

  • Exposure to individual dialogues

    The percentage of individual dialogues with fixed subjects used by the patients out all planned, and reason(s) for non-participation

    Baseline - 6-month follow-up

  • Adverse Events

    The number of adverse events related to the intervention

    Baseline-1-year follow-up

Secondary Outcomes (8)

  • Fidelity of physical exercise training

    Baseline - 6-month follow-up

  • Fidelity of motivating interviewing

    Baseline - 6-month follow-up

  • Fidelity of individual dialogues

    Baseline - 6-month follow-up

  • Fidelity of group sessions

    Baseline - 6-month follow-up

  • Fidelity of nutritional counselling

    Baseline - 6-month follow-up

  • +3 more secondary outcomes

Study Arms (1)

HAPPY

EXPERIMENTAL

Single arm longitudinal design.

Other: Multimodal interdisciplinary rehabilitation programme (HAPPY)

Interventions

A 6-month multimodal interdisciplinary rehabilitation programme abbreviated HAPPY was tested. The programme consisted of motivating interviewing technique, individual dialogues with fixed subjects, individual supervised physical exercise training, relaxation exercises, nutritional counselling, and group sessions (a combination of topics and exchange of experiences) with patients and relatives. To reach patients at home, the team phoned patients, who were also given tablets with access to the project's homepage and a digital physical exercise programme.

HAPPY

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients were accepted for NMA-HSCT
  • ≥ 18 years
  • able to read and understand Danish and to follow the study protocol.

You may not qualify if:

  • psychological diagnosis
  • contra-indications for progressive exercise training
  • inability to walk or stand
  • instable bone lesions
  • severe neurological deficiencies
  • severe cardiac or cardio vascular diseases, severe pulmonary global insufficiency.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dep. of Hem. Aarhus Universitetshospital

Aarhus, Denmark

Location

Study Officials

  • Astrid Lindman

    Aarhus University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 23, 2021

First Posted

March 15, 2021

Study Start

September 1, 2018

Primary Completion

January 15, 2021

Study Completion

July 1, 2021

Last Updated

November 10, 2021

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations